*Some Market data delayed by 15 mins.

Nuvation Bio Inc.

Symbol: NUVB (NYSE)
3.92 ▲ (14.47%) 0.495

Company Description:
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Key Stats
  • Today's Open: $3.48
  • Today's High: $4.081
  • Today's Low: $3.401
  • Today's Volume: 22.01M
  • Yesterday Close: $3.42
  • Yesterday High: $3.48
  • Yesterday Low: $3.15
  • Yesterday Volume: 12.01M
  • Last Min Volume: 111
  • Last Min High: $3.915
  • Last Min Low: $3.915
  • Last Min VWAP: $3.915
Company Profile
  • Name: Nuvation Bio Inc.
  • Website: https://www.nuvationbio.com
  • Listed Date: 2021-02-10
  • Location: SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001811063
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $1.33B
  • Round Lot: 100
  • Outstanding Shares: 342.27M
  • Asset Type: CS
RECENT FILINGS FOR NUVB
Filing Date Filing Type Format
2025-08-13 4 View
2025-08-07 10-Q View
2025-08-07 8-K View
2025-07-17 SCHEDULE 13G View
2025-06-18 4 View
2025-06-18 4 View
2025-06-18 4 View
2025-06-18 4 View
2025-06-18 4 View
2025-06-11 8-K View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 8-K View
2025-05-12 SCHEDULE 13G/A View
2025-05-07 10-Q View
2025-05-07 8-K View
2025-05-06 4 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.